Lv3
310 积分 2024-09-07 加入
Metabolic traits of T cells and the implications in autoimmune diseases
13天前
已关闭
Successful Treatment of Pityriasis Rubra Pilaris With Deucravacitinib
13天前
已关闭
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
13天前
已完结
Electrophysiological properties of developing phrenic motoneurons in the cat
29天前
已完结
Off-Label Use of Deucravacitinib in Dermatology: A Systematic Review
1个月前
已完结
Off-Label Use of Deucravacitinib in Dermatology: A Systematic Review
1个月前
已完结
ANCA-associated vasculitis
1个月前
已完结
Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis
2个月前
已完结
Tyrosine kinase 2 inhibitors in autoimmune diseases
2个月前
已完结
Treatment of lichen planopilaris with the TYK-2 inhibitor deucravacitinib
2个月前
已完结
皖公网安备34019202002308
